Brand/Generic Settlements To Be Subject Of Senate Judiciary Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA is among the parties scheduled to testify at the panel next week, which could coincide with the reintroduction of Sen. Kohl’s bill to curb settlements.
You may also be interested in...
Bristol/Sanofi Receive FTC Subpoena Over Failed Plavix Settlement With Apotex
Both firms say they will comply with investigation seeking documents.
Bristol/Sanofi Receive FTC Subpoena Over Failed Plavix Settlement With Apotex
Both firms say they will comply with investigation seeking documents.
Supreme Court Denies Certiorari To FTC v. Schering-Plough
The high court denies the Federal Trade Commission’s petition to hear the case regarding issues raised by brand companies’ reverse payments to generic firms.